The mission of the Northeast Amyotrophic Lateral Sclerosis Consortium® (NEALS) is to rapidly translate scientific advances into clinical research and new treatments for people with Amyotrophic Lateral Sclerosis (ALS) and motor neuron disease.
To achieve our goal, NEALS functions as an academic research consortium and a resource for the ALS community. Learn more about our structure.
The NEALS Consortium is committed to the principles of open scientific communication, peer review, full and open disclosure of potential conflicts of interest, and democratic governance of its organization and activities.
NEALS was founded in 1995 with 9 academic clinical centers in the New England area. With help from The ALS Association's TREAT ALS Network, Muscular Dystrophy Association, and our generous donors, the NEALS membership has grown to over 140 research centers committed to performing research in ALS and MND.